Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastiaan Engelborghs

Showing results (151-160 of 359) with videos related to

Pageof 36
Sort By:
Palliative Medicine|July 26, 2019
Limited engagement in, yet clear preferences for advance care planning in young-onset dementia: An exploratory interview-study with family caregiversRomy Van Rickstal, Aline De Vleminck, Melissa D Aldridge, et al.
Neurobiology of Aging|June 4, 2018
Genetic screening in early-onset dementia patients with unclear phenotype: relevance for clinical diagnosisFederica Perrone, Rita Cacace, Sara Van Mossevelde, et al.
Alzheimer'S Research & Therapy|May 16, 2020
Long-term safety and tolerability of atabecestat (JNJ-54861911), an oral BACE1 inhibitor, in early Alzheimer's disease spectrum patients: a randomized, double-blind, placebo-controlled study and a two-period extension studyGerald Novak, Johannes Rolf Streffer, Maarten Timmers, et al.
Brain : a Journal of Neurology|May 5, 2022
Biomarker A+T-: is this Alzheimer's disease or not? A combined CSF and pathology studyEleonora M Vromen, Sterre C M de Boer, Charlotte E Teunissen, et al.
Frontiers in Neurology|November 3, 2025
Real-world brain volumetry in multiple sclerosis: importance of methodological consistency and clinical relevance of gray matter atrophyJoke Temmerman, Ann Vanremoortel, Maria Bjerke, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 4, 2011
Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization InitiativeHugo Vanderstichele, Mirko Bibl, Sebastiaan Engelborghs, et al.
Acta Neuropathologica Communications|November 21, 2013
Promoter DNA methylation regulates progranulin expression and is altered in FTLDJulia Banzhaf-Strathmann, Rainer Claus, Oliver Mücke, et al.
Ear and Hearing|January 6, 2023
Accelerated Cognitive Decline Associated With Hearing Loss and Bilateral Vestibulopathy: Insights From a Prospective Cross-Sectional Study Using the Repeatable Battery for the Assessment of Neuropsychological Status Adjusted for the Hearing Impaired in the DFNA9 PopulationHanne Gommeren, Joyce Bosmans, Julie Moyaert, et al.
Acta Neurologica Belgica|July 28, 2020
Practices and opinions about disclosure of the diagnosis of Alzheimer's disease to patients with MCI or dementia: a survey among Belgian medical experts in the field of dementiaEric Mormont, Jean-Christophe Bier, Rose Bruffaerts, et al.
Scientific Reports|September 26, 2025
Assessing the link between cerebellar volume and cognitive function in Alzheimer's disease: a pilot studyDeborah Van Rossem, Gert-Jan Allemeersch, Nuno Barros, et al.
Pageof 36

Showing results (151-160 of 359) with videos related to

Sort By:
Pageof 36
Palliative Medicine|July 26, 2019
Limited engagement in, yet clear preferences for advance care planning in young-onset dementia: An exploratory interview-study with family caregiversRomy Van Rickstal, Aline De Vleminck, Melissa D Aldridge, et al.
Neurobiology of Aging|June 4, 2018
Genetic screening in early-onset dementia patients with unclear phenotype: relevance for clinical diagnosisFederica Perrone, Rita Cacace, Sara Van Mossevelde, et al.
Alzheimer'S Research & Therapy|May 16, 2020
Long-term safety and tolerability of atabecestat (JNJ-54861911), an oral BACE1 inhibitor, in early Alzheimer's disease spectrum patients: a randomized, double-blind, placebo-controlled study and a two-period extension studyGerald Novak, Johannes Rolf Streffer, Maarten Timmers, et al.
Brain : a Journal of Neurology|May 5, 2022
Biomarker A+T-: is this Alzheimer's disease or not? A combined CSF and pathology studyEleonora M Vromen, Sterre C M de Boer, Charlotte E Teunissen, et al.
Frontiers in Neurology|November 3, 2025
Real-world brain volumetry in multiple sclerosis: importance of methodological consistency and clinical relevance of gray matter atrophyJoke Temmerman, Ann Vanremoortel, Maria Bjerke, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 4, 2011
Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization InitiativeHugo Vanderstichele, Mirko Bibl, Sebastiaan Engelborghs, et al.
Acta Neuropathologica Communications|November 21, 2013
Promoter DNA methylation regulates progranulin expression and is altered in FTLDJulia Banzhaf-Strathmann, Rainer Claus, Oliver Mücke, et al.
Ear and Hearing|January 6, 2023
Accelerated Cognitive Decline Associated With Hearing Loss and Bilateral Vestibulopathy: Insights From a Prospective Cross-Sectional Study Using the Repeatable Battery for the Assessment of Neuropsychological Status Adjusted for the Hearing Impaired in the DFNA9 PopulationHanne Gommeren, Joyce Bosmans, Julie Moyaert, et al.
Acta Neurologica Belgica|July 28, 2020
Practices and opinions about disclosure of the diagnosis of Alzheimer's disease to patients with MCI or dementia: a survey among Belgian medical experts in the field of dementiaEric Mormont, Jean-Christophe Bier, Rose Bruffaerts, et al.
Scientific Reports|September 26, 2025
Assessing the link between cerebellar volume and cognitive function in Alzheimer's disease: a pilot studyDeborah Van Rossem, Gert-Jan Allemeersch, Nuno Barros, et al.
Pageof 36